Literature DB >> 33323992

Extending treatment eligibility for chronic hepatitis B virus infection.

Anna L McNaughton1, Maud Lemoine2, Christo van Rensburg3, Philippa C Matthews4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33323992     DOI： 10.1038/s41575-020-00398-x

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Comparing the Efficacy and Safety of Treating Chronic Hepatitis B Infection during Pregnancy with Lamivudine, Telbivudine, and Tenofovir: A Meta-analysis.

Authors:  Shahnaz Sali; Mohammad Darvishi; Mojtaba GhasemiAdl; Meisam Akhlaghdoust; Azin Mirzazadeh; Somayeh Elikaei Behjati; Hossein Sheikh-Zeinolabedini; Shervin Shokouhi; Soheil Tavakolpour
Journal:  J Clin Transl Hepatol       Date:  2019-09-02
  1 in total
  7 in total

Review 1.  Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B.

Authors:  Amir M Mohareb; Joseph Larmarange; Arthur Y Kim; Patrick A Coffie; Menan Gérard Kouamé; Anders Boyd; Kenneth A Freedberg; Emily P Hyle
Journal:  Lancet HIV       Date:  2022-07-08       Impact factor: 16.070

2.  Metabolic Regulation of Hepatitis B Virus Infection in HBV-Transgenic Mice.

Authors:  Wenning Lan; Yang Wang; Zixiong Zhou; Xia Sun; Yun Zhang; Fangrong Zhang
Journal:  Metabolites       Date:  2022-03-25

3.  Prevalence and Predictors of Liver Fibrosis in People Living with Hepatitis B in Senegal.

Authors:  Adrià Ramírez Mena; Ndeye Fatou Ngom; Judicaël Tine; Kine Ndiaye; Louise Fortes; Ousseynou Ndiaye; Maguette Fall; Assietou Gaye; Daye Ka; Moussa Seydi; Gilles Wandeler
Journal:  Viruses       Date:  2022-07-24       Impact factor: 5.818

4.  Impact of National Volume-Based Procurement on the Procurement Volumes and Spending for Antiviral Medications of Hepatitis B Virus.

Authors:  Jing Yuan; Z Kevin Lu; Xiaomo Xiong; Tai-Ying Lee; Huang Huang; Bin Jiang
Journal:  Front Pharmacol       Date:  2022-06-06       Impact factor: 5.988

Review 5.  Sexual Dimorphism in Chronic Hepatitis B Virus (HBV) Infection: Evidence to Inform Elimination Efforts.

Authors:  Robin Brown; Philip Goulder; Philippa C Matthews
Journal:  Wellcome Open Res       Date:  2022-04-26

6.  Targeted antiviral treatment of hepatitis B virus in culturally and linguistically diverse populations to achieve elimination targets in Australia.

Authors:  Belaynew W Taye; Patricia C Valery; Paul J Clark
Journal:  J Viral Hepat       Date:  2022-07-02       Impact factor: 3.517

7.  Ultra-long-acting (XLA) antivirals for chronic viral hepatitis.

Authors:  Vicente Soriano; Carmen Alvarez; Benson Edagwa; Carmen de Mendoza; Noemí Montoya; Ana Treviño; Howard Gendelman
Journal:  Int J Infect Dis       Date:  2021-10-30       Impact factor: 12.074
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.